![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » GENAERA RECEIVES PATENT FOR GENE VARIANTS OF INTERLEUKIN-9 RECEPTOR
GENAERA RECEIVES PATENT FOR GENE VARIANTS OF INTERLEUKIN-9 RECEPTOR
June 23, 2006
Genaera Corporation today announced issuance by the United States Patent and Trademark Office of patent number 7,056,698 entitled "Nucleic Acids Encoding Interleukin-9 Receptor Variants."
Drug Newswire (http://www.euro2day.gr/articlesfna/16501875/)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct